Recent Security Class Actions

INSTADOSE PHARMA CORP (US TRADING VENUE: INSD)

Company Name:INSTADOSE PHARMA CORP
Stock Symbol:US TRADING VENUE: INSD
Class Period Start:12/08/2020
Class Period End (inclusive):11/24/2021
Filing Deadline:02/28/2022

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Instadose had performed inadequate due diligence into the Business Combination and/or ignored significant red flags associated with Instadose Canada; (ii) Instadose's internal controls and policies were inadequate to detect and/or prevent impermissible trading activity by control persons of the Company; (iii) the foregoing subjected Instadose to a heightened risk of regulatory scrutiny and enforcement action; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.